Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

Improved Travel With Coronavirus Testing

Reduce the risk of facing restrictions and quarantine measures at your destination with SARS-CoV-2 pre-flight testing

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Centogene’s latest Scientific Publications

Genetic Causes for Late Onset Neuropathy

Slowly progressive health issues in the elderly are usually equated to a general…

Novel X-linked Syndrome Identified

Defects in many X-chromosomal genes are known to cause neurodevelopmental problems in…

Expanding the Genetics of Impaired Neurodevelopment

The nervous system is particularly vulnerable to genetic defects, and novel pertinent…

A Novel Therapeutic Concept for Fabry Disease

Fabry disease is caused by mutations that affect the lysosomal enzyme α-galactosidase, but…

Continuum of ‘Distinct’ Neurodegenerative Disorders

A neurodegenerative disorder may affect distinct types of nerve cells in a…

Novel Genetic Cause for Absence of Kidneys

Renal defects are rather common in inherited disorders, while absence of kidneys is very…

Utility of CENTOGENE’s Charity Genomic Testing

Genetic disorders are prevalent in many developing countries, but access to genomic…

Characterizing a Rare Disease Through a Global Effort

In the rare disease field, the compilation of large patient cohorts is a challenge, but…

Recognition of CENTOGENE’s Scientific Expertise

Editorial board members in scientific journals are selected from the most-respected…

A Potential Link Between COVID-19 and Parkinson’s Disease

The potential consequences of a SARS-CoV-2 infection are only beginning to be understood.…

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass. And ROSTOCK, Germany and BERLIN, Nov. 13, 2020 (Globe Newswire) ─ CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases...

Read more

GENT, Belgium and CAMBRIDGE, Mass., USA, and ROSTOCK, Germany and BERLIN– November 9, 2020: Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 09. November 2020

  • Die Nachfrage nach flexiblen Lösungen für zuverlässige COVID-19-Tests nimmt weiter...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 05, 2020 (GLOBE NEWSWIRE)

  • CENTOGENE expands its SARS-CoV-2 testing solution to Berlin Brandenburg...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 05. November 2020

  • Nach erfolgreicher Inbetriebnahme von SARS-CoV-2-Testzentren an drei großen...
Read more

CAMBRIDGE, Mass. und ROSTOCK und BERLIN, Deutschland, 20. Oktober 2020 -

Centogene N.V. (Nasdaq: CNTG), ein weltweit führendes Unternehmen, welches...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 19, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more